Skip to content

Skin, hair and appearance

Does anything work for skin and hair?

Beauty compounds, collagen, skin color and hair. What was found for creams and what was found for shots are very different, and the pages keep them apart.

44 compounds studied for this · 13 with a completed trial of a hundred people or more · 5 with no study in people at all

Copper peptides for skin and hair: what real people saw

What has actually been measured here

This page lists the compounds studied for skin, hair and appearance. These pages work the other way round. They take one goal at a time and list every compound by how many people it was measured in, most first. Each shows what the study found, and the trials that found nothing are counted.

Or open all 4 of these together in the finder.

Strong and Moderate 13

At least one finished trial that gave the compound to a hundred people or more. That tells you how much has been measured. It does not tell you whether it will work for you. The math sits under every band.

Argireline

Moderate. At least one finished study in people, and at least 100 people who took it. 4 completed trials, 155 people given it.7 reported
7 cited

A skin cream peptide sold as a 'Botox-like' wrinkle softener for lines from facial expressions.

PeptideCosmetic

Matrixyl

Moderate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 114 people given it.7 reported
2 cited

A popular skin cream peptide that tells skin to make more collagen. It is studied for fine lines and firmness.

PeptideCosmetic

Melanotan II

Strong. At least two finished studies in people, and at least 1,000 people who took it. 5 completed trials, 1,310 people given it.9 reported
8 cited

An unapproved tanning and sex drive shot. It has real safety concerns.

PeptideMelanocortin

Melanotan I

Moderate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 170 people given it.8 reported
6 cited

An FDA-approved drug that darkens the skin to protect people with a rare condition that makes sunlight painful.

PeptideMelanocortin

Idebenone

Moderate. At least one finished study in people, and at least 100 people who took it. 5 completed trials, 732 people given it.
5 cited

Approved in the European Union for one rare inherited eye disease that causes sudden vision loss. The approval came unde...

SupplementAntioxidant

Nicotinamide

Moderate. At least one finished study in people, and at least 100 people who took it. 4 completed trials, 591 people given it.2 reported
4 cited

A plain form of vitamin B3. In a large final-stage study of 386 people at high risk, 500 mg twice a day cut new skin can...

SupplementLongevity

Dersimelagon

Moderate. At least one finished study in people, and at least 100 people who took it. 1 completed trial, 165 people given it.1 reported
2 cited

A daily pill that switches on MC1R, the skin's tanning receptor. It is a small-molecule cousin of afamelanotide. In Janu...

Small moleculeMelanocortin

Botulinum toxin type A

Strong. At least two finished studies in people, and at least 1,000 people who took it. 2 completed trials, 1,681 people given it.5 reported
3 cited

A large bacterial protein that works as an enzyme, not a peptide. It was first approved in 1991 and carries the FDA's st...

BiologicCosmetic

Pegcetacoplan

Strong. At least two finished studies in people, and at least 1,000 people who took it. 3 completed trials, 1,258 people given it.3 reported
4 cited

One drug with two unrelated approvals. As Empaveli, a drip under the skin, it treats a rare blood disease called PNH. Th...

PeptideImmune

PQQ

Moderate. At least one finished study in people, and at least 100 people who took it. 3 completed trials, 116 people given it.5 reported
4 cited

Sold to grow new mitochondria, the cell's power plants. In a six-week training study, PQQ raised one mitochondria-buildi...

SupplementAntioxidant

PT-141

Strong. At least two finished studies in people, and at least 1,000 people who took it. 4 completed trials, 2,355 people given it.9 reported
4 cited

An FDA-approved shot for low sexual desire in women who have not gone through menopause.

PeptideMelanocortin

Sermorelin with ipamorelin

Moderate. At least one finished study in people, and at least 100 people who took it. 1 completed trial, 117 people given it.8 reported
3 cited

This is the blend most likely to come from a compounding pharmacy with a prescriber's name on it. It is usually a nightl...

BlendGrowth Hormone

Ziconotide

Moderate. At least one finished study in people, and at least 100 people who took it. 2 completed trials, 111 people given it.2 reported
2 cited

A pain drug made from cone snail venom, approved in 2004 for severe long-term pain. It only works when a pump implanted...

PeptideNootropic & CNS

Limited and Preliminary 26

Someone has been given it and a result was published, but in fewer than a hundred people. Or the studies in people only watched and never gave anybody anything. The math on each card says exactly how thin.

GHK-Cu

Limited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, 99 people given it.7 reported
7 cited

A tiny copper-carrying peptide your body makes. It is common in skin creams and has been studied for healing wounds and...

PeptideHealing & Recovery

SNAP-8

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 24 people given it.7 reported
2 cited

A skin cream peptide, a longer version of Argireline, sold to soften expression wrinkles.

PeptideCosmetic

GLOW blend

Limited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, 22 people given it.9 reported
3 cited

GLOW is a seller's mix of three peptides in one vial, usually 50 mg GHK-Cu plus 10 mg each of BPC-157 and TB-500. It is...

BlendCosmetic

Melanotan II with PT-141

Limited. People have taken it in a published study, but fewer than 100 of them. 3 completed trials, 10 people given it.7 reported
3 cited

Two drugs from the melanocortin family used together, and one is what the other turns into. That is the whole problem. B...

BlendMelanocortin

AHK-Cu with GHK-Cu

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 13 people given it.5 reported
2 cited

Two copper peptides in one serum, sold for hair and skin. There is not one published paper on AHK-Cu under that name. So...

BlendCosmetic

GLOW capsules

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 13 people given it.6 reported
2 cited

The skin blend usually sold as a shot, sold here as a pill you swallow. A capsule usually has 2 mg GHK-Cu, 500 microgram...

BlendCosmetic

Argireline with Matrixyl and SNAP-8

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 60 people given it.6 reported
1 cited

The standard three-peptide face serum. One of the three has a proper study in 60 people against a dummy cream. The other...

BlendCosmetic

Collagen peptides

Limited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, 69 people given it.4 reported
3 cited

A huge supplement market built on studies that almost never test collagen against the one thing that would settle it: th...

SupplementCosmetic

RLS-1496

Preliminary. Studied in people, but no published study has had people take it. 1 human study where nobody was given it, 1 registered with no result.1 reported
2 cited

Rubedo's skin cream meant to clear worn-out skin cells. In an early study in psoriasis, eczema and sun-damaged skin, it...

Small moleculeAnti-aging

Verteporfin

Preliminary. Studied in people, but no published study has had people take it. 1 human study where nobody was given it.2 reported
1 cited

Verteporfin is an approved eye drug. Injected into wounds in mice, it led to healing without scars in a famous 2021 pape...

Small moleculeHealing & Recovery

GHK-Cu with zinc thymulin

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 13 people given it.7 reported
2 cited

A pharmacy-made scalp serum in a dropper bottle. It usually has 5 mg/mL of copper peptide with 10 micrograms/mL of zinc...

BlendCosmetic

Glutathione

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 54 people given it.8 reported
2 cited

The body's main antioxidant inside cells, made of three amino acids. People take it for skin, for the liver and to clean...

SupplementAntioxidant

KLOW blend

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 13 people given it.11 reported
2 cited

KLOW is a seller's mix of four peptides in one vial, usually 50 mg GHK-Cu plus 10 mg each of KPV, BPC-157 and TB-500. It...

BlendHealing & Recovery

NAD+ with glutathione

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 21 people given it.5 reported
2 cited

Usually two separate drips or shots given in one clinic visit, not one vial, because no premixed product is standard. NA...

BlendLongevity

Quad healing blend

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 13 people given it.8 reported
1 cited

The same four peptides as KLOW, mixed in very different amounts. It is usually 5 mg TB-500, 5 mg BPC-157, 10 mg KPV and...

BlendHealing & Recovery

NAD+ / B Complex

Limited. People have taken it in a published study, but fewer than 100 of them. 5 completed trials, 34 people given it.8 reported
5 cited

Injectable NAD+ mixed with B12, and sometimes B6, sold as a clinic drip or as a vial for shots under the skin. No study...

BlendLongevity

Nomlabofusp

Limited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, 28 people given it.
5 cited

A replacement for frataxin, the protein people with Friedreich ataxia are missing. It is joined to a short peptide that...

BiologicNootropic & CNS

Sermorelin / GHRP

Limited. People have taken it in a published study, but fewer than 100 of them. 4 completed trials, 56 people given it.9 reported
5 cited

The standard growth hormone blend from compounding pharmacies, usually 5 mg sermorelin with 5 mg GHRP-2 in one 10 mg via...

BlendGrowth Hormone

Bivamelagon

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people.1 reported
4 cited

A pill meant to turn down appetite. It works on the same brain switch, called MC4R, as setmelanotide, which is a shot. A...

Small moleculeMelanocortin

Halofuginone

Preliminary. Studied in people, but no published study has had people take it. 3 human studies where nobody was given it, 1 registered with no result.2 reported
4 cited

It has barely been tested in people. 24 cancer patients took it by mouth in an early safety study, and nausea capped the...

Small moleculeLongevity

Dermorphin

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 11 people given it.2 reported
3 cited

A seven amino acid opioid from the skin of South American frogs. In animals it is 30 to 40 times stronger than morphine....

PeptideNootropic & CNS

Ginsenoside Rg3

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 24 people given it.
2 cited

A compound from ginseng that pushes worn-out cells in opposite directions depending on the cell. In a dish it brought wo...

SupplementLongevity

Urolithin B

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people.
1 cited

Sold on the good name of urolithin A, which has human studies. Urolithin B has none. Its muscle result comes from muscle...

SupplementMuscle & Performance

PT-141 with oxytocin

Limited. People have taken it in a published study, but fewer than 100 of them. 3 completed trials, 10 people given it.6 reported
3 cited

A 15 mg vial, usually 10 mg bremelanotide with 5 mg oxytocin. So two thirds of the powder is bremelanotide and one third...

BlendMelanocortin

PL8177

Preliminary. Studied in people, but no published study has had people take it. 2 human studies where nobody was given it.2 reported
2 cited

Palatin's peptide pill that switches on MC1R, for ulcerative colitis. In a small mid-stage study, 33 percent went into r...

PeptideMelanocortin

Setmelanotide

Limited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 38 people given it.4 reported
2 cited

An FDA-approved shot for rare genetic types of obesity, where a broken gene stops the brain from feeling full.

PeptideMelanocortin

Animal or lab only, and nothing measured 5

Studied in animals or in cells in a dish, or studied in people for something else entirely. Listed, not hidden, because knowing a thing has not been tested in a person is the useful part.

Reading on this goal

What the number counts, exactly

The number on each card is how many sources on that compound’s page are studies in people. It is counted the same simple way for all 453 compounds. You can check any of it by opening the profile and reading the list of sources. That is the whole point of showing a number at all.

It counts what we cite. It does not claim how much research exists. A compound with three studies in people here may have thirty in print, and the honest thing to say is that we have read and listed three. It is also not a quality score. Three small, loose studies count the same as three careful ones. So the groups tell you how much was measured in people, and the profile page tells you how well.

Other goals